I do hope it works out.
That's not quite democratized, but a first-world rush could well happen. I wonder how much costs can be brought down by automation.
This technology is in clinical trials, but people who need it now don't have years to wait for it. There's a lot of work to be done in engineering a legal landscape that allows people to access experimental treatments at costs as low as we can manage, without exposing manufacturers to damaging liability. I recommend this article about Jake Stillman's experience participating in clinical trials for terminal cancer (https://bessstillman.substack.com/p/please-be-dying-but-not-...) and this article by Ruxandra Teslo about bureaucratic bottlenecks in medical research (https://www.persuasion.community/p/medical-research-is-hopel...).